119 related articles for article (PubMed ID: 21489876)
1. FKBPs in chromatin modification and cancer.
Yao YL; Liang YC; Huang HH; Yang WM
Curr Opin Pharmacol; 2011 Aug; 11(4):301-7. PubMed ID: 21489876
[TBL] [Abstract][Full Text] [Related]
2. FK506 binding proteins as targets in anticancer therapy.
Romano S; Di Pace A; Sorrentino A; Bisogni R; Sivero L; Romano MF
Anticancer Agents Med Chem; 2010 Nov; 10(9):651-6. PubMed ID: 21182472
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of different outcomes for drug-eluting stents that release sirolimus or tacrolimus.
Giordano A
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):159-68. PubMed ID: 20205050
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
Dumont FJ; Kastner C; Iacovone F; Fischer PA
J Pharmacol Exp Ther; 1994 Jan; 268(1):32-41. PubMed ID: 7507994
[TBL] [Abstract][Full Text] [Related]
6. A nuclear FK506-binding protein is a histone chaperone regulating rDNA silencing.
Kuzuhara T; Horikoshi M
Nat Struct Mol Biol; 2004 Mar; 11(3):275-83. PubMed ID: 14981505
[TBL] [Abstract][Full Text] [Related]
7. FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention.
Annett S; Moore G; Robson T
Pharmacol Ther; 2020 Nov; 215():107623. PubMed ID: 32622856
[TBL] [Abstract][Full Text] [Related]
8. FKBP family proteins as promising new biomarkers for cancer.
Solassol J; Mange A; Maudelonde T
Curr Opin Pharmacol; 2011 Aug; 11(4):320-5. PubMed ID: 21514221
[TBL] [Abstract][Full Text] [Related]
9. Tête-à-tête: the function of FKBPs in plant development.
Geisler M; Bailly A
Trends Plant Sci; 2007 Oct; 12(10):465-73. PubMed ID: 17826298
[TBL] [Abstract][Full Text] [Related]
10. Identification of functional FKB protein in Echinococcus granulosus: its involvement in the protoscolicidal action of rapamycin derivates and in calcium homeostasis.
Cumino AC; Lamenza P; Denegri GM
Int J Parasitol; 2010 May; 40(6):651-61. PubMed ID: 20005877
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52.
Gopalakrishnan R; Kozany C; Gaali S; Kress C; Hoogeland B; Bracher A; Hausch F
J Med Chem; 2012 May; 55(9):4114-22. PubMed ID: 22455444
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51.
Imai A; Sahara H; Tamura Y; Jimbow K; Saito T; Ezoe K; Yotsuyanagi T; Sato N
Eur J Immunol; 2007 Jul; 37(7):1730-8. PubMed ID: 17523132
[TBL] [Abstract][Full Text] [Related]
13. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities.
Monaghan P; Bell A
Mol Biochem Parasitol; 2005 Feb; 139(2):185-95. PubMed ID: 15664653
[TBL] [Abstract][Full Text] [Related]
14. Targeting FKBP isoforms with small-molecule ligands.
Blackburn EA; Walkinshaw MD
Curr Opin Pharmacol; 2011 Aug; 11(4):365-71. PubMed ID: 21803654
[TBL] [Abstract][Full Text] [Related]
15. The FKBP-associated protein FAP48 is an antiproliferative molecule and a player in T cell activation that increases IL2 synthesis.
Krummrei U; Baulieu EE; Chambraud B
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2444-9. PubMed ID: 12604780
[TBL] [Abstract][Full Text] [Related]
16. Chromatin modifying agents - the cutting edge of anticancer therapy.
Kwa FA; Balcerczyk A; Licciardi P; El-Osta A; Karagiannis TC
Drug Discov Today; 2011 Jul; 16(13-14):543-7. PubMed ID: 21664485
[TBL] [Abstract][Full Text] [Related]
17. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
[TBL] [Abstract][Full Text] [Related]
18. FKBP38-Bcl-2 interaction: a novel link to chemoresistance.
Choi BH; Yoon HS
Curr Opin Pharmacol; 2011 Aug; 11(4):354-9. PubMed ID: 21571591
[TBL] [Abstract][Full Text] [Related]
19. FKBP51 regulation of AKT/protein kinase B phosphorylation.
Wang L
Curr Opin Pharmacol; 2011 Aug; 11(4):360-4. PubMed ID: 21498116
[TBL] [Abstract][Full Text] [Related]
20. Functional drift of sequence attributes in the FK506-binding proteins (FKBPs).
Galat A
J Chem Inf Model; 2008 May; 48(5):1118-30. PubMed ID: 18412331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
